SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Thursday reported a loss of $22.3 million in its third quarter.

On a per-share basis, the San Carlos, California-based company said it had a loss of 5 cents.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.

The biotechnology company posted revenue of $121.5 million in the period.

Iovance Biotherapeutics expects full-year revenue in the range of $410 million to $420 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA